Clinical trial / 2025
A whole-food, plant-based diet with exercise improved glycaemic control and reduced medication use in individuals with type 2 diabetes.
In a 24-week parallel-arm randomized trial, 169 adults with type 2 diabetes were assigned to an intensive whole-food, plant-based intervention with moderate exercise (PB+Ex) or standard medical care (SMC). Compared with SMC, the PB+Ex intervention resulted in greater HbA1c reductions at week 12 (-22 vs -7 mmol/mol [-2.0% vs -0.7%]; p<0.0001) and week 24 (-16 vs -8 mmol/mol [-1.4% vs -0.7%]; p=0.01). Furthermore, 63% of medicated PB+Ex participants reduced glucose-lowering medications compared to 24% in SMC (p=0.006), and 23% with baseline HbA1c <75 mmol/mol achieved remission. PB+Ex also led to reductions in weight (-2.7 kg; p<0.0001), C-reactive protein (-11 nmol/l; p=0.005), and cardiovascular medication use.
- Study type
- Randomized controlled trial
- Who was studied
- 169 adults aged 18-75 years with type 2 diabetes in the Marshall Islands
- What was measured
- Glycaemic control (HbA1c, glucose, insulin, HOMA-IR) and medication use
THE PAPER
A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial.
Hanick CJ, Peterson CM, Davis BC, Sabaté J, Kelly JH. Diabetologia, 2025.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.